GLUT1, GLUT3 Expression and 18FDG-PET/CT in Human Malignant Melanoma: What Relationship Exists? New Insights and Perspectives

Background: Malignant melanoma is the most aggressive of skin cancers and the 19th most common cancer worldwide, with an estimated age-standardized incidence rate of 2.8–3.1 per 100,000; although there have been clear advances in therapeutic treatment, the prognosis of MM patients with Breslow thick...

Full description

Bibliographic Details
Main Authors: Gerardo Cazzato, Anna Colagrande, Antonietta Cimmino, Caterina Abbatepaolo, Emilio Bellitti, Paolo Romita, Lucia Lospalluti, Caterina Foti, Francesca Arezzo, Vera Loizzi, Teresa Lettini, Sara Sablone, Leonardo Resta, Gennaro Cormio, Giuseppe Ingravallo, Roberta Rossi
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/10/11/3090
_version_ 1827677039011823616
author Gerardo Cazzato
Anna Colagrande
Antonietta Cimmino
Caterina Abbatepaolo
Emilio Bellitti
Paolo Romita
Lucia Lospalluti
Caterina Foti
Francesca Arezzo
Vera Loizzi
Teresa Lettini
Sara Sablone
Leonardo Resta
Gennaro Cormio
Giuseppe Ingravallo
Roberta Rossi
author_facet Gerardo Cazzato
Anna Colagrande
Antonietta Cimmino
Caterina Abbatepaolo
Emilio Bellitti
Paolo Romita
Lucia Lospalluti
Caterina Foti
Francesca Arezzo
Vera Loizzi
Teresa Lettini
Sara Sablone
Leonardo Resta
Gennaro Cormio
Giuseppe Ingravallo
Roberta Rossi
author_sort Gerardo Cazzato
collection DOAJ
description Background: Malignant melanoma is the most aggressive of skin cancers and the 19th most common cancer worldwide, with an estimated age-standardized incidence rate of 2.8–3.1 per 100,000; although there have been clear advances in therapeutic treatment, the prognosis of MM patients with Breslow thickness greater than 1 mm is still quite poor today. The study of how melanoma cells manage to survive and proliferate by consuming glucose has been partially addressed in the literature, but some rather interesting results are starting to be present. Methods: A systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and a search of PubMed and Web of Sciences (WoS) databases was performed until 27 September 2021 using the terms: glucose transporter 1 and 3 and GLUT1/3 in combination with each of the following: melanoma, neoplasm and immunohistochemistry. Results: In total, 46 records were initially identified in the literature search, of which six were duplicates. After screening for eligibility and inclusion criteria, 16 publications were ultimately included. Conclusions: the results discussed regarding the role and expression of GLUT are still far from definitive, but further steps toward understanding and stopping this mechanism have, at least in part, been taken. New studies and new discoveries should lead to further clarification of some aspects since the various mechanisms of glucose uptake by neoplastic cells are not limited to the transporters of the GLUT family alone.
first_indexed 2024-03-10T05:36:35Z
format Article
id doaj.art-add43add2b6a4482a075cc3b0644852e
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T05:36:35Z
publishDate 2021-11-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-add43add2b6a4482a075cc3b0644852e2023-11-22T22:51:09ZengMDPI AGCells2073-44092021-11-011011309010.3390/cells10113090GLUT1, GLUT3 Expression and 18FDG-PET/CT in Human Malignant Melanoma: What Relationship Exists? New Insights and PerspectivesGerardo Cazzato0Anna Colagrande1Antonietta Cimmino2Caterina Abbatepaolo3Emilio Bellitti4Paolo Romita5Lucia Lospalluti6Caterina Foti7Francesca Arezzo8Vera Loizzi9Teresa Lettini10Sara Sablone11Leonardo Resta12Gennaro Cormio13Giuseppe Ingravallo14Roberta Rossi15Section of Pathology, Department of Emergency and Organ Transplantation (DETO), University of Bari, “Aldo Moro”, 70124 Bari, ItalySection of Pathology, Department of Emergency and Organ Transplantation (DETO), University of Bari, “Aldo Moro”, 70124 Bari, ItalySection of Pathology, Department of Emergency and Organ Transplantation (DETO), University of Bari, “Aldo Moro”, 70124 Bari, ItalySection of Pathology, Department of Emergency and Organ Transplantation (DETO), University of Bari, “Aldo Moro”, 70124 Bari, ItalySection of Pathology, Department of Emergency and Organ Transplantation (DETO), University of Bari, “Aldo Moro”, 70124 Bari, ItalySection of Dermatology, Department of Biomedical Sciences and Human Oncology, University of Bari, “Aldo Moro”, 70124 Bari, ItalySection of Dermatology, Department of Biomedical Sciences and Human Oncology, University of Bari, “Aldo Moro”, 70124 Bari, ItalySection of Dermatology, Department of Biomedical Sciences and Human Oncology, University of Bari, “Aldo Moro”, 70124 Bari, ItalySection of Ginecology and Obstetrics, Department of Biomedical Sciences and Human Oncology, University of Bari, “Aldo Moro”, 70124 Bari, ItalySection of Ginecology and Obstetrics, Department of Biomedical Sciences and Human Oncology, University of Bari, “Aldo Moro”, 70124 Bari, ItalySection of Pathology, Department of Emergency and Organ Transplantation (DETO), University of Bari, “Aldo Moro”, 70124 Bari, ItalySection of Legal Medicine, Department of Interdisciplinary Medicine, Bari Policlinico Hospital, University of Bari, “Aldo Moro”, 70124 Bari, ItalySection of Pathology, Department of Emergency and Organ Transplantation (DETO), University of Bari, “Aldo Moro”, 70124 Bari, ItalySection of Ginecology and Obstetrics, Department of Biomedical Sciences and Human Oncology, University of Bari, “Aldo Moro”, 70124 Bari, ItalySection of Pathology, Department of Emergency and Organ Transplantation (DETO), University of Bari, “Aldo Moro”, 70124 Bari, ItalySection of Pathology, Department of Emergency and Organ Transplantation (DETO), University of Bari, “Aldo Moro”, 70124 Bari, ItalyBackground: Malignant melanoma is the most aggressive of skin cancers and the 19th most common cancer worldwide, with an estimated age-standardized incidence rate of 2.8–3.1 per 100,000; although there have been clear advances in therapeutic treatment, the prognosis of MM patients with Breslow thickness greater than 1 mm is still quite poor today. The study of how melanoma cells manage to survive and proliferate by consuming glucose has been partially addressed in the literature, but some rather interesting results are starting to be present. Methods: A systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and a search of PubMed and Web of Sciences (WoS) databases was performed until 27 September 2021 using the terms: glucose transporter 1 and 3 and GLUT1/3 in combination with each of the following: melanoma, neoplasm and immunohistochemistry. Results: In total, 46 records were initially identified in the literature search, of which six were duplicates. After screening for eligibility and inclusion criteria, 16 publications were ultimately included. Conclusions: the results discussed regarding the role and expression of GLUT are still far from definitive, but further steps toward understanding and stopping this mechanism have, at least in part, been taken. New studies and new discoveries should lead to further clarification of some aspects since the various mechanisms of glucose uptake by neoplastic cells are not limited to the transporters of the GLUT family alone.https://www.mdpi.com/2073-4409/10/11/3090GLUT1GLUT3malignant melanomaimmunohistochemistryperspectives
spellingShingle Gerardo Cazzato
Anna Colagrande
Antonietta Cimmino
Caterina Abbatepaolo
Emilio Bellitti
Paolo Romita
Lucia Lospalluti
Caterina Foti
Francesca Arezzo
Vera Loizzi
Teresa Lettini
Sara Sablone
Leonardo Resta
Gennaro Cormio
Giuseppe Ingravallo
Roberta Rossi
GLUT1, GLUT3 Expression and 18FDG-PET/CT in Human Malignant Melanoma: What Relationship Exists? New Insights and Perspectives
Cells
GLUT1
GLUT3
malignant melanoma
immunohistochemistry
perspectives
title GLUT1, GLUT3 Expression and 18FDG-PET/CT in Human Malignant Melanoma: What Relationship Exists? New Insights and Perspectives
title_full GLUT1, GLUT3 Expression and 18FDG-PET/CT in Human Malignant Melanoma: What Relationship Exists? New Insights and Perspectives
title_fullStr GLUT1, GLUT3 Expression and 18FDG-PET/CT in Human Malignant Melanoma: What Relationship Exists? New Insights and Perspectives
title_full_unstemmed GLUT1, GLUT3 Expression and 18FDG-PET/CT in Human Malignant Melanoma: What Relationship Exists? New Insights and Perspectives
title_short GLUT1, GLUT3 Expression and 18FDG-PET/CT in Human Malignant Melanoma: What Relationship Exists? New Insights and Perspectives
title_sort glut1 glut3 expression and 18fdg pet ct in human malignant melanoma what relationship exists new insights and perspectives
topic GLUT1
GLUT3
malignant melanoma
immunohistochemistry
perspectives
url https://www.mdpi.com/2073-4409/10/11/3090
work_keys_str_mv AT gerardocazzato glut1glut3expressionand18fdgpetctinhumanmalignantmelanomawhatrelationshipexistsnewinsightsandperspectives
AT annacolagrande glut1glut3expressionand18fdgpetctinhumanmalignantmelanomawhatrelationshipexistsnewinsightsandperspectives
AT antoniettacimmino glut1glut3expressionand18fdgpetctinhumanmalignantmelanomawhatrelationshipexistsnewinsightsandperspectives
AT caterinaabbatepaolo glut1glut3expressionand18fdgpetctinhumanmalignantmelanomawhatrelationshipexistsnewinsightsandperspectives
AT emiliobellitti glut1glut3expressionand18fdgpetctinhumanmalignantmelanomawhatrelationshipexistsnewinsightsandperspectives
AT paoloromita glut1glut3expressionand18fdgpetctinhumanmalignantmelanomawhatrelationshipexistsnewinsightsandperspectives
AT lucialospalluti glut1glut3expressionand18fdgpetctinhumanmalignantmelanomawhatrelationshipexistsnewinsightsandperspectives
AT caterinafoti glut1glut3expressionand18fdgpetctinhumanmalignantmelanomawhatrelationshipexistsnewinsightsandperspectives
AT francescaarezzo glut1glut3expressionand18fdgpetctinhumanmalignantmelanomawhatrelationshipexistsnewinsightsandperspectives
AT veraloizzi glut1glut3expressionand18fdgpetctinhumanmalignantmelanomawhatrelationshipexistsnewinsightsandperspectives
AT teresalettini glut1glut3expressionand18fdgpetctinhumanmalignantmelanomawhatrelationshipexistsnewinsightsandperspectives
AT sarasablone glut1glut3expressionand18fdgpetctinhumanmalignantmelanomawhatrelationshipexistsnewinsightsandperspectives
AT leonardoresta glut1glut3expressionand18fdgpetctinhumanmalignantmelanomawhatrelationshipexistsnewinsightsandperspectives
AT gennarocormio glut1glut3expressionand18fdgpetctinhumanmalignantmelanomawhatrelationshipexistsnewinsightsandperspectives
AT giuseppeingravallo glut1glut3expressionand18fdgpetctinhumanmalignantmelanomawhatrelationshipexistsnewinsightsandperspectives
AT robertarossi glut1glut3expressionand18fdgpetctinhumanmalignantmelanomawhatrelationshipexistsnewinsightsandperspectives